Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults
Clinical trial NCT03541499 · COMPLETED
Trial details
- NCT number
- NCT03541499
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2020-05-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.